America Living With AIDS

National Institute of Allergy and Infectious Diseases (NIAID). 1990. NIAID
Responds to ACT-UP Allegations and Demands. Washington, D.C.: NIAID Office of
Communications, National Institutes of Health.
National Institutes of Health. 1990. AIDS: 1989 Research Accomplishments. Bethesda,
Md.: National Institutes of Health.
Nolan, K. 1990. AIDS and pediatric research. Evaluation Review 14:464-481.
Novick, A. 1989. Clinical trials with vulnerable or disrespected subjects. AIDS and
Public Policy Journal 4:125-130.
Palca, J. 1991. Conflict over release of clinical research data. Science 251:374-375.
Richman, D. 1989. Public access to experimental drug therapy: AIDS raises yet
another conflict between freedom of the individual and welfare of the individual and
public. Journal of Infectious Diseases 159:412-415.
Rothman, D.J. 1987. Ethical and social issues in the development of new drugs and
vaccines. Bulletin of the New York Academy of Medicine 63:557-568.
Rothman, D.J. 1987. Ethics and human experimentation: Henry Beecher revisited.
New England Journal of Medicine 317:1195-1199.
Silverman, W.A. 1986. Human Experimentation: A Guided Step into the Unknown.
New York: Oxford University Press.
Steinbrook, R., and B. Lo. 1990. Informing physicians about promising new
treatments for severe illnesses. Journal of the American Medical Association
263:2078-2082.
U.S. Congress. House. 1988. 100th Congress, 2d Session. House Committee on
Government Operations. AIDS Drugs: Where Are They? Report 100-1092.
Valdiserri, R.O., G.M. Tama, and M. Ho. 1988. The role of community advisory
committees in clinical trials of anti-HIV agents. IRB: A Review of Human Subjects
Research 10(4):5-7.
Vogel, D. 1989. AIDS and the politics of drug lag. The Public Interest 96:73-85.
Weiss, R., and L. Mazade. 1990. Surrogate Endpoints in Evaluating the Effectiveness of
Drugs Against HIV Infection and AIDS. Washington, D.C.: National Academy Press.